Premium Nahrungsergänzungsmittel | artgerecht

Immune Activation Markers – Definition and Clinical Role

Immune activation markers are molecules on immune cells that indicate whether the immune system is active. They help physicians detect inflammation, infections, or immune disorders.

Regular tips about health Regular tips about health

Things worth knowing about "Immune Activation Markers"

Immune activation markers are molecules on immune cells that indicate whether the immune system is active. They help physicians detect inflammation, infections, or immune disorders.

What Are Immune Activation Markers?

Immune activation markers are specific molecules – primarily proteins on the surface of immune cells or in blood serum – that reflect the current activation state of the immune system. They are upregulated in response to infections, inflammation, autoimmune diseases, or other immunological processes, making them valuable diagnostic and research tools.

The key immune cell types on which these markers are measured include T lymphocytes, B lymphocytes, natural killer (NK) cells, and monocytes.

Common Immune Activation Markers

There is a wide range of markers studied depending on the cell type and clinical context:

CD25 (IL-2 receptor alpha): Upregulated on activated T cells, indicating ongoing T cell activation.
CD69: An early activation marker that appears shortly after stimulation on T, B, and NK cells.
HLA-DR: A major histocompatibility complex (MHC class II) molecule strongly expressed on activated T cells and monocytes.
CD38: Overexpressed on T cells during chronic infections and certain hematological malignancies.
CD71 (Transferrin receptor): Reflects increased metabolic activity and proliferation of activated cells.
PD-1 (CD279): A marker of exhausted or chronically activated T cells, relevant in chronic infections and cancer immunotherapy.
Ki-67: A proliferation marker indicating active cell division.

Clinical Significance

Infectious Diseases

In infections such as HIV, tuberculosis, or viral hepatitis, certain activation markers such as HLA-DR and CD38 on CD8-positive T cells are significantly elevated. The degree of immune activation often correlates with disease severity and treatment response. In HIV infection, elevated immune activation markers are considered an independent predictor of disease progression.

Autoimmune Diseases

In conditions such as systemic lupus erythematosus (SLE), rheumatoid arthritis, or multiple sclerosis, immune activation markers are persistently elevated, reflecting chronic, misdirected immune responses. These markers help identify disease flares and monitor the response to immunosuppressive therapies.

Oncology and Immunotherapy

In oncology, immune activation markers play an increasingly important role. Markers such as PD-1 and PD-L1 are direct targets of modern checkpoint inhibitors. Measuring these markers helps identify patients suitable for immunotherapy and assess treatment response.

Transplant Medicine

Following organ or stem cell transplantation, immune activation markers are used to detect impending rejection reactions early and guide therapeutic interventions.

Diagnostic Methods

Immune activation markers are primarily measured using flow cytometry. In this method, blood cells are labeled with fluorescence-tagged antibodies that bind specifically to the respective surface markers. The cells are then analyzed in a laser beam, enabling precise quantification of individual marker expression.

In addition, soluble activation markers such as sCD25 (soluble IL-2 receptor) or neopterin can be measured in blood serum to detect systemic immune activation.

Interpretation of Results

The interpretation of immune activation markers must always be considered within the clinical context. Elevated values may indicate active infections, inflammation, autoimmune processes, or malignant diseases. An isolated elevation of a single marker is generally not conclusive; only the combination of multiple markers allows reliable conclusions about the underlying condition.

References

Deeks, S.G. et al. (2004): Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood, 104(4), 942–947.
Appay, V. & Sauce, D. (2008): Immune activation and inflammation in HIV-1 infection: causes and consequences. Journal of Pathology, 214(2), 231–241.
World Health Organization (WHO): Laboratory Guidelines for Enumerating CD4 T Lymphocytes in the Context of HIV/AIDS. WHO Press, Geneva.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.